Literature DB >> 10066815

The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling.

N Gupta1, A M Scharenberg, D A Fruman, L C Cantley, J P Kinet, E O Long.   

Abstract

Coligation of FcgammaRIIb1 with the B cell receptor (BCR) or FcepsilonRI on mast cells inhibits B cell or mast cell activation. Activity of the inositol phosphatase SHIP is required for this negative signal. In vitro, SHIP catalyzes the conversion of the phosphoinositide 3-kinase (PI3K) product phosphatidylinositol 3,4, 5-trisphosphate (PIP3) into phosphatidylinositol 3,4-bisphosphate. Recent data demonstrate that coligation of FcgammaRIIb1 with BCR inhibits PIP3-dependent Btk (Bruton's tyrosine kinase) activation and the Btk-dependent generation of inositol trisphosphate that regulates sustained calcium influx. In this study, we provide evidence that coligation of FcgammaRIIb1 with BCR induces binding of PI3K to SHIP. This interaction is mediated by the binding of the SH2 domains of the p85 subunit of PI3K to a tyrosine-based motif in the C-terminal region of SHIP. Furthermore, the generation of phosphatidylinositol 3,4-bisphosphate was only partially reduced during coligation of BCR with FcgammaRIIb1 despite a drastic reduction in PIP3. In contrast to the complete inhibition of Tec kinase-dependent calcium signaling, activation of the serine/threonine kinase Akt was partially preserved during BCR and FcgammaRIIb1 coligation. The association of PI3K with SHIP may serve to activate PI3K and to regulate downstream events such as B cell activation-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066815     DOI: 10.1074/jbc.274.11.7489

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling.

Authors:  M J Aman; S F Walk; M E March; H P Su; D J Carver; K S Ravichandran
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.

Authors:  Saskia M Brachmann; Kohjiro Ueki; Jeffrey A Engelman; Ronald C Kahn; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma.

Authors:  Qi-Wen Fan; Zachary A Knight; David D Goldenberg; Wei Yu; Keith E Mostov; David Stokoe; Kevan M Shokat; William A Weiss
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

Review 4.  Signal-dependent membrane targeting by pleckstrin homology (PH) domains.

Authors:  M A Lemmon; K M Ferguson
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

5.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity.

Authors:  Luisa Beltran; Claire Chaussade; Bart Vanhaesebroeck; Pedro Rodriguez Cutillas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

7.  Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells.

Authors:  Jing Lu; Michael S Caplan; Dan Li; Tamas Jilling
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-03-20       Impact factor: 4.052

Review 8.  Inhibitors of B-cell receptor signaling for patients with B-cell malignancies.

Authors:  Michael Y Choi; Thomas J Kipps
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

Review 9.  B-cell receptor signaling as a driver of lymphoma development and evolution.

Authors:  Carsten U Niemann; Adrian Wiestner
Journal:  Semin Cancer Biol       Date:  2013-09-20       Impact factor: 15.707

10.  The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop.

Authors:  James N Psathas; Patrick J Doonan; Pichai Raman; Bruce D Freedman; Andy J Minn; Andrei Thomas-Tikhonenko
Journal:  Blood       Date:  2013-10-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.